Vitamin K-dependent clotting factors, combined deficiency of, type 1
MONDO:0010187Combined vitamin K-dependent clotting factors deficiency (VKCFD) is a congenital bleeding disorder resulting from variably decreased levels of coagulation factors II, VII, IX and X, as well as natural anticoagulants protein C, protein S and protein Z.
Also known as: GGCX congenital vitamin K-dependent coagulation factors combined deficiency, congenital vitamin K-dependent coagulation factors combined deficiency caused by mutation in GGCX, hereditary combined deficiency of factors II, VII, IX and X, vitamin K-dependent clotting factors, combined deficiency of, type 1, FMFD 3, VKCFD1, Vkcfd, factors II, VII, IX, and X, combined deficiency of
13 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
Battlefield plasma goes civil: can a powder save trauma victims?
Disease control CompletedThis study tested a freeze-dried plasma product that can be mixed with water in 6 minutes, avoiding the long thaw time of standard plasma. It included 42 trauma patients with severe bleeding who needed blood transfusions. The goal was to see if faster plasma delivery could improv…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New blood product could cut transfusions in major surgeries
Disease control CompletedThis study tested a pathogen-reduced version of cryoprecipitate, a blood product that helps blood clot, in 208 patients undergoing liver transplant or heart surgery. The goal was to see if having this product readily available could stop bleeding early and reduce the need for oth…
Phase 4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC